$CANB Can B Corp. Discusses Significant Delta-8 and Isomer Capacity Growth with The Stock Day Podcast
https://www.newsfilecorp.com/release/97728
Phoenix, Arizona--(Newsfile Corp. - September 27, 2021) - The Stock Day Podcast welcomed Can B Corp. (OTCQB: CANB) (CANB) ("the Company"
, a health & wellness company providing the highest quality hemp derived cannabinoid products. CEO of the Company, Marco Alfonsi, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about the Company's latest projects. "We have a manufacturing division, hemp division, and medical device division," explained Alfonsi. "Let's start with our Pure Health products," said Alfonsi. "We have doubled our capacity," he shared. "We are getting NSF certified, which will give us the ability to do pharmaceutical goods," said Alfonsi. He also shared that the Company's Canbiola brand is now available in hundreds of doctor's offices.
Alfonsi then elaborated on the progress of the Company's medical device division. "We moved into Michigan and we are now in approximately 25 physician offices," said Alfonsi. "By opening up Michigan, we are exceeding our revenue model there."
"However, the exciting part of our business that we are getting into is the hemp division," continued Alfonsi, before elaborating on the Company's purchase of Colorado facility assets. "Our capacity has grown dramatically," said Alfonsi. "We're able to do around 3,000 liters per month of [Delta-8 and other isomers]," he explained. "We were able to bring in a whole new section of business for us because now we are able to make our own isolate."
"What do you think the future of the hemp industry looks like over the next two to three quarters?" asked Jolly. "For my company, we are in a boom right now," said Alfonsi. "We have control of 100% of our supply chain," he added. "By creating isomers with Delta-8, which is very hot on the street right now, we are able to create profit," said Alfonsi, before elaborating on the potential of isomers.
"With all of these acquisitions, what do you expect for the Company over the next 12 months?" asked Jolly. Alfonsi then discussed the significant revenue potential of the Company's hemp division, paired with the potential of their additional divisions.
"Do you feel that your market cap is very undervalued?" asked Jolly. "Yes," said Alfonsi. "If you liquidated all of my assets today, you would have about $12 million in hard assets and we have 22 million shares issued," he explained. "Honestly, in my opinion the valuation should be twice the market cap that it is now."
To close the interview, Alfonsi expressed his confidence in the Company's potential as they continue to expand and grow across numerous divisions.
To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7949229-can-b-cor...ay-podcast.
https://www.newsfilecorp.com/release/97728
Phoenix, Arizona--(Newsfile Corp. - September 27, 2021) - The Stock Day Podcast welcomed Can B Corp. (OTCQB: CANB) (CANB) ("the Company"
, a health & wellness company providing the highest quality hemp derived cannabinoid products. CEO of the Company, Marco Alfonsi, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's latest projects. "We have a manufacturing division, hemp division, and medical device division," explained Alfonsi. "Let's start with our Pure Health products," said Alfonsi. "We have doubled our capacity," he shared. "We are getting NSF certified, which will give us the ability to do pharmaceutical goods," said Alfonsi. He also shared that the Company's Canbiola brand is now available in hundreds of doctor's offices.
Alfonsi then elaborated on the progress of the Company's medical device division. "We moved into Michigan and we are now in approximately 25 physician offices," said Alfonsi. "By opening up Michigan, we are exceeding our revenue model there."
"However, the exciting part of our business that we are getting into is the hemp division," continued Alfonsi, before elaborating on the Company's purchase of Colorado facility assets. "Our capacity has grown dramatically," said Alfonsi. "We're able to do around 3,000 liters per month of [Delta-8 and other isomers]," he explained. "We were able to bring in a whole new section of business for us because now we are able to make our own isolate."
"What do you think the future of the hemp industry looks like over the next two to three quarters?" asked Jolly. "For my company, we are in a boom right now," said Alfonsi. "We have control of 100% of our supply chain," he added. "By creating isomers with Delta-8, which is very hot on the street right now, we are able to create profit," said Alfonsi, before elaborating on the potential of isomers.
"With all of these acquisitions, what do you expect for the Company over the next 12 months?" asked Jolly. Alfonsi then discussed the significant revenue potential of the Company's hemp division, paired with the potential of their additional divisions.
"Do you feel that your market cap is very undervalued?" asked Jolly. "Yes," said Alfonsi. "If you liquidated all of my assets today, you would have about $12 million in hard assets and we have 22 million shares issued," he explained. "Honestly, in my opinion the valuation should be twice the market cap that it is now."
To close the interview, Alfonsi expressed his confidence in the Company's potential as they continue to expand and grow across numerous divisions.
To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7949229-can-b-cor...ay-podcast.
